X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with ALEMBIC LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA ALEMBIC LTD ELDER PHARMA/
ALEMBIC LTD
 
P/E (TTM) x -0.2 119.3 - View Chart
P/BV x 0.1 4.4 2.3% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 ELDER PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ALEMBIC LTD
Mar-16
ELDER PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs38053 719.7%   
Low Rs18829 641.6%   
Sales per share (Unadj.) Rs491.24.7 10,407.3%  
Earnings per share (Unadj.) Rs-3.28.8 -36.3%  
Cash flow per share (Unadj.) Rs14.49.0 160.0%  
Dividends per share (Unadj.) Rs00.15 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs376.527.7 1,357.9%  
Shares outstanding (eoy) m20.54267.03 7.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.68.7 6.6%   
Avg P/E ratio x-89.34.7 -1,907.8%  
P/CF ratio (eoy) x19.74.6 432.3%  
Price / Book Value ratio x0.81.5 50.9%  
Dividend payout %01.7 0.0%   
Avg Mkt Cap Rs m5,83310,962 53.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,179238 915.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,0891,260 800.5%  
Other income Rs m257264 97.3%   
Total revenues Rs m10,3461,524 678.8%   
Gross profit Rs m-79283 -956.4%  
Depreciation Rs m36161 588.4%   
Interest Rs m2,7560 918,766.7%   
Profit before tax Rs m-3,653285 -1,282.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m02,096 0.0%   
Extraordinary Inc (Exp) Rs m3,713-32 -11,530.1%   
Tax Rs m1256 2,051.6%   
Profit after tax Rs m-652,343 -2.8%  
Gross profit margin %-7.86.6 -119.5%  
Effective tax rate %-3.42.1 -160.0%   
Net profit margin %-0.6185.9 -0.3%  
BALANCE SHEET DATA
Current assets Rs m9,2401,689 547.1%   
Current liabilities Rs m9,998486 2,056.3%   
Net working cap to sales %-7.595.4 -7.9%  
Current ratio x0.93.5 26.6%  
Inventory Days Days46217 21.3%  
Debtors Days Days6081 74.0%  
Net fixed assets Rs m10,1241,624 623.3%   
Share capital Rs m206534 38.5%   
"Free" reserves Rs m5,5825,960 93.7%   
Net worth Rs m7,7347,404 104.5%   
Long term debt Rs m4,889104 4,687.4%   
Total assets Rs m22,8828,010 285.7%  
Interest coverage x-0.3950.7 -0.0%   
Debt to equity ratio x0.60 4,487.7%  
Sales to assets ratio x0.40.2 280.2%   
Return on assets %11.829.3 40.2%  
Return on equity %-0.831.6 -2.7%  
Return on capital %22.331.3 71.3%  
Exports to sales %3.02.9 103.2%   
Imports to sales %0.428.9 1.5%   
Exports (fob) Rs m30737 826.4%   
Imports (cif) Rs m43364 11.9%   
Fx inflow Rs m30737 826.4%   
Fx outflow Rs m125365 34.3%   
Net fx Rs m181-328 -55.3%   
CASH FLOW
From Operations Rs m11,754346 3,401.1%  
From Investments Rs m-561-48 1,177.5%  
From Financial Activity Rs m-6,762-301 2,246.4%  
Net Cashflow Rs m4,432-3 -147,723.3%  

Share Holding

Indian Promoters % 39.6 64.0 61.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 0.2 3,750.0%  
FIIs % 16.8 9.7 173.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 26.1 138.3%  
Shareholders   16,479 54,701 30.1%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   STRIDES SHASUN LTD  AJANTA PHARMA  SUVEN LIFE  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; Realty Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a dull note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - BIOCON LTD COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS